Cargando…

Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis

Liver fibrosis consists in the accumulation of extracellular matrix components mainly derived from activated hepatic stellate cells. This is commonly the result of chronic liver injury repair and represents an important health concern. As liver biopsy is burdened with many drawbacks, not surprisingl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smirne, Carlo, Rigamonti, Cristina, De Benedittis, Carla, Sainaghi, Pier Paolo, Bellan, Mattia, Burlone, Michela Emma, Castello, Luigi Mario, Avanzi, Gian Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754881/ https://www.ncbi.nlm.nih.gov/pubmed/31583026 http://dx.doi.org/10.1155/2019/2304931

Ejemplares similares

Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders
por: Bellan, Mattia, et al.
Publicado: (2020)

Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis
por: Bellan, Mattia, et al.
Publicado: (2019)

The Gas6/TAM System and Multiple Sclerosis
por: Bellan, Mattia, et al.
Publicado: (2016)

Role of the Gas6/TAM System as a Disease Marker and Potential Drug Target
por: Sainaghi, Pier Paolo, et al.
Publicado: (2021)

Growth Arrest-Specific Gene 6 Administration Ameliorates Sepsis-Induced Organ Damage in Mice and Reduces ROS Formation In Vitro
por: Salmi, Livia, et al.
Publicado: (2021)

Gas6/TAM Axis in Sepsis: Time to Consider Its Potential Role as a Therapeutic Target
por: Salmi, Livia, et al.
Publicado: (2019)

Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients
por: Rizzi, Manuela, et al.
Publicado: (2023)

Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders
por: Bellan, Mattia, et al.
Publicado: (2019)

New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
por: Pagani, Sara, et al.
Publicado: (2020)

Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients
por: De Benedittis, Carla, et al.
Publicado: (2020)

Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study
por: Rigamonti, Cristina, et al.
Publicado: (2020)

Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases
por: Bellan, Mattia, et al.
Publicado: (2020)

COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters
por: Rizzi, Manuela, et al.
Publicado: (2023)

Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents
por: Gualerzi, Alessandro, et al.
Publicado: (2018)

Are Baseline Levels of Gas6 and Soluble Mer Predictors of Mortality and Organ Damage in Patients with Sepsis? The Need-Speed Trial Database
por: Gavelli, Francesco, et al.
Publicado: (2022)

Liver Stiffness, Not Fat Liver Content, Predicts the Length of QTc Interval in Patients with Chronic Liver Disease
por: Bellan, Mattia, et al.
Publicado: (2019)

Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients
por: Tonello, Stelvio, et al.
Publicado: (2022)

“War to the knife” against thromboinflammation to protect endothelial function of COVID-19 patients
por: Guglielmetti, Gabriele, et al.
Publicado: (2020)

Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy
por: Varrasi, Claudia, et al.
Publicado: (2022)

Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients
por: Smirne, Carlo, et al.
Publicado: (2022)

Hyperglycemic Hyperosmolar State: A Pragmatic Approach to Properly Manage Sodium Derangements
por: Baldrighi, Marco, et al.
Publicado: (2018)

Comment on “Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis”
por: Bellan, Mattia, et al.
Publicado: (2019)

Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis
por: Lorena, Maria, et al.
Publicado: (2022)

Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19
por: Mennuni, Marco G., et al.
Publicado: (2021)

Management of sepsis and septic shock in the emergency department
por: Gavelli, Francesco, et al.
Publicado: (2021)

Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease
por: Smirne, Carlo, et al.
Publicado: (2020)

Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein
por: Rizzi, Manuela, et al.
Publicado: (2022)

Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation
por: Grossini, Elena, et al.
Publicado: (2021)

Comment on “Excessive Sodium Bicarbonate Infusion May Result in Osmotic Demyelination Syndrome During Treatment of Diabetic Ketoacidosis: A Case Report” by Hsieh et al.
por: Castello, Luigi Mario, et al.
Publicado: (2019)

Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort
por: Zecca, Erika, et al.
Publicado: (2022)

The Role of Osteopontin as a Diagnostic and Prognostic Biomarker in Sepsis and Septic Shock
por: Castello, Luigi Mario, et al.
Publicado: (2019)

Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review
por: Bellan, Mattia, et al.
Publicado: (2018)

GAS6/TAM Pathway Signaling in Hemostasis and Thrombosis
por: Law, Luke A., et al.
Publicado: (2018)

Gas6/TAM Receptors in Systemic Lupus Erythematosus
por: Cohen, Philip L., et al.
Publicado: (2019)

Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms
por: Moia, Riccardo, et al.
Publicado: (2021)

Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients
por: Tonello, Stelvio, et al.
Publicado: (2023)

Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors
por: Apostolo, Daria, et al.
Publicado: (2023)

Sofosbuvir‐based therapies in genotype 2 hepatitis C virus cirrhosis: A real‐life experience with focus on ribavirin dose
por: Smirne, Carlo, et al.
Publicado: (2021)

Targeting Gas6/TAM in cancer cells and tumor microenvironment
por: Wu, Guiling, et al.
Publicado: (2018)

Molecular insights of Gas6/TAM in cancer development and therapy
por: Wu, Guiling, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7o8lu403tl5pvps1pm09pmdrfa